WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Avalo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher Ryan SullivanCFO2026-09-1010,185$17.62
$179.46kSell
Christopher Ryan SullivanCFO2026-09-1010,185$8.04
$81.89kBuy
Mittie DoyleMed2026-08-28679$20.00
$13.58kSell
Mittie DoyleMed2026-08-28679$8.04
$5.46kBuy
Christopher Ryan SullivanCFO2026-08-1831,031$20.06
$622.33kSell
Christopher Ryan SullivanCFO2026-08-1831,031$9.88
$306.59kBuy
Christopher Ryan SullivanCFO2026-08-1737,945$9.88
$374.90kBuy
Mittie DoyleMed2026-08-171,000$12.65
$12.65kBuy
Christopher Ryan SullivanCFO2026-08-1737,945$19.85
$753.32kSell
Christopher Ryan SullivanCFO2026-08-173,749$19.94
$74.76kSell

1 of 8

AVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTX insiders and whales buy or sell their stock.

AVTX Shareholders

What type of owners hold Avalo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC96.24%51,615,185$861.46MInsider
Robert Moscato Jr.16.69%8,952,643$149.42MInsider
Randal Jones11.86%6,359,900$106.15MInsider
Steven Boyd4.37%2,345,714$39.15MInsider
Patrick J. Crutcher3.05%1,634,771$27.28MInsider
Mpm Bioventures V LP1.11%595,436$9.94MInsider
Apple Tree Partners IV LP1.11%595,436$9.94MInsider
Harry R. Weller1.11%594,245$9.92MInsider
M. James Barrett1.11%594,245$9.92MInsider
Peter J. Barris1.11%594,245$9.92MInsider

1 of 3

AVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTX0.09%99.91%Net SellingNet Selling
FTH0.05%31.12%Net BuyingNet Buying
TBPH0.09%82.27%Net SellingNet Selling
IMMX0.08%13.64%Net Buying
RIGL0.07%99.93%Net SellingNet Selling
View Top Biotech Stocks

Avalo Therapeutics Stock Ownership FAQ

Who owns Avalo Therapeutics?

Avalo Therapeutics (NASDAQ: AVTX) is owned by 0.13% institutional shareholders, 152.06% Avalo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Avalo Therapeutics shareholder, owning 51.62M shares representing 96.24% of the company. Armistice Capital LLC's Avalo Therapeutics shares are currently valued at $855.26M.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.